Facial Emotion Recognition in Patients Who Committed Sexual Assault Against Children: an EEG Study
EMOREC
1 other identifier
interventional
30
1 country
1
Brief Summary
This study aims to compare the emotional processing in sexual offenders against children versus healthy volunteers using an objective electrophysiological measurement (EEG) during a facial emotion stimuli presentation task. Secondary goal is to assess emotion recognition performances in this population and evaluate the impact of various factors on these performances (type of emotion, age and sex of person expressing the emotion, neuropsychological and cognitive abilities of the subjects).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 20, 2022
CompletedFirst Posted
Study publicly available on registry
May 20, 2022
CompletedStudy Start
First participant enrolled
July 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2025
CompletedJuly 24, 2025
July 1, 2025
2.8 years
April 20, 2022
July 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Amplitude of LPP during the facial emotion stimuli presentation task
The facial emotion stimuli presentation task is based on pictures from the Radbout Faces Database (RaFD). It includes pictures of male and female subjects, adults and children expressing positive, neutral or negative emotion. During the task, cerebral activity will be recorded by EEG to measure amplitude and latency of the LPP (Late Positive Potential).
one day
Secondary Outcomes (6)
Facial emotion recognition abilities
one day
TOM-15 (Theory Of Mind 15)
one day
TAS20 (Toronto Alexithymia Scale 20)
one day
PCL-R SV (Psychopathy Checklist Revised - Short Version)
one day
QCAE (Questionnaire of Cognitive and Affective Empathy)
one day
- +1 more secondary outcomes
Study Arms (2)
Sexual offenders against children
EXPERIMENTALsexual offenders against children
Healthy controls
ACTIVE COMPARATORHealthy controls
Interventions
1\. ROUTINE CARE : retrieval of sociodemographic characteristics, medical and psychological assessment, multidisciplinary meeting about the patient
2\. RUN-IN PERIOD : * Eligibility criteria will be assessed during the multidisciplinary meeting; * Study presentation, delivery of the information note and consent form; 3. STUDY: * Collection of consent form; * Facial emotion stimuli presentation task with EEG recording and facial emotion recording task; * Neuropsychological evaluation (TOM-15); * Scales and questionnaires (TAS-20, PCL-R SV, CECAQ, QCAE); * Debriefing.
Eligibility Criteria
You may qualify if:
- Right-handed ;
- Patient refered to the referral platform for treatment of sexual offenders in Le Vinatier Hospital Center for evaluation of child abuse ;
- Without any Axis 1 disorder ;
- Having given informed consent ;
- Affiliated to French social health care
You may not qualify if:
- Intellectual disability (identified during routine care in the referral platform for treatment of sexual offenders);
- Poor understanding of tests and scales instructions ;
- Neurological or neurodevelopmental history resulting in cognitive impairment with loss of autonomy ;
- Gardianship or other tutelage measure
- Healthy controls :
- Right-handed ;
- Without criminal background ;
- Without any DSM-5 psychiatric disorder (past or present, personal or familial in a first-degree relative) ;
- Non-caregiver employee of Le Vinatier Hospital Center.
- Intellectual disability (using fNART if clinical suspicion during run-in period);
- Poor understanding of tests and scales instructions ;
- Neurological or neurodevelopmental history resulting in cognitive impairment with loss of autonomy ;
- Gardianship or other tutelage measure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Le Vinatier
Bron, Auvergne-Rhône-Alpes, 69678, France
Study Officials
- PRINCIPAL INVESTIGATOR
Sabine MOUCHET, PH
CH le Vinatier
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Apart from investigators in charge of inclusions, outcome assessors will not know to which group the subjects belong.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 20, 2022
First Posted
May 20, 2022
Study Start
July 12, 2022
Primary Completion
May 15, 2025
Study Completion
May 15, 2025
Last Updated
July 24, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share